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Limitations of creatinine during cimetidine as a filtration marker in
renal disease. B.A.C. van Acker, G.C.M. Koomen, M.G. Koopman, L.
Arisz, Renal Unit, Academic Medical Center, Amsterdam, The Neth-
erlands. Cimetidine has been shown to block tubular secretion of
creatinine by competitive inhibition of the tubular cationic secretory
pathway for creatinine. To determine the reliability of creatinine during
oral ingestion of cimetidine as a measure of glomerular filtration rate
(GFR), we compared simultaneous clearances of inulin and creatinine
in 16 patients with various renal diseases (GFR 22—68 mI/mm/I .73 m2).
Inulin, PAH (continuous infusion) and endogenous creatinine clearance
were measured before administration of cimetidine (baseline) and
during successive 3-hour urine collections during a 24-hour period with
cimetidine 200 mg/3 hours. At baseline, creatinine relative to inulin
clearance (CIJCl) ranged from 1.14 to 2.26. During cimetidine,
Clcr/Clin approached unity in eight patients (1.02 0.03, mean SD),
but considerably exceeded unity in eight others (1.33 0.14). This
second group had a higher C1r/Clin at baseline (1.80 0.31 vs. 1.26
0.11, P < 0.005) and proteinuria was present more often (8/8 vs. 2/8). By
plotting Clr/Clio during cimetidine vs. filtration fraction (FF), we
observed Cl/Cl1 values near one in case of normal or increased FF.
However, at decreased FF a negative relationship was present: the
more FF was decreased, the more Clr/Clin exceeded unity. Statistical
analysis (nonlinear regression and F-test) showed that a two-line model
fitted the data better than a single horizontal line (P < 0.005). A
breakpoint was observed at FF = 0.21, with a 95% confidence interval
of 0.17 to 0.24. It can be concluded that during cimetidine creatinine has
a limited use as a filtration marker in renal disease. In patients with a
decreased FF, cimetidine does not completely inhibit tubular secretion
of creatinine. Whether this is due to an alternative secretory pathway
for creatinine, or whether an increased peritubular blood flow is
involved in this, requires further study.
Decreased anti-heparan sulfate staining of the GBM in lupus nephritis:
Possible role role of histones. J. van den Born, C. Kramers, M.A.H.
Bakker, M.C.J. van Bruggen, R.M. Termaat, H.B.P.M. Dijkman,
K.J.M. Assmann and J.H.M. Berden, Department of Medicine, Divi-
sion Nephrology and Pathology, University of Njmegen, Njjmegen,
The Netherlands. Recently, we developed monoclonal antibodies
(mAbs) against the core protein (JM-72) and against the heparan sulfate
(HS) glycosaminoglycan side chain (JM-403) of heparan sulfate proteo-
glycan (HSPG), the major proteoglycan of the GBM. Indirect immuno-
fluorescence (hF) on normal human kidney tissue reveals for both
mAbs a brilliant staining of the GBM. With these mAbs we investigated
with hF in a double staining technique the HSPG distribution in renal
biopsies from 16 patients with SLE nephritis. Although anti-HSPG-core
JM-72 staining was normal, staining with anti-HS JM-403 was com-
pletely absent in 15 out of 16 biopsies, This can be due to either
disappearance of HS from the GBM or to masking the negatively
charged HS by positively charged molecules. We have found previously
that anti-DNA antibodies can bind to HS via the histone part of
histone/DNA particles (J Autoimm 3:531, 1990). The effect of histones
on the binding of mAb JM-403 to HS was evaluated in ELISA and in
renal perfusion studies in the rat. In ELISA histones could inhibit
dose-dependently the binding of JM-403 to HS. For the perfusion
studies rat kidneys were perfused with histones, and subsequently
flushed with saline and snap frozen in liquid nitrogen. Histone binding
to the GBM was controlled with poly- and monoclonal anti-histone
antibodies. In these kidneys a remarkable but not complete reduction of
anti-HS JM-403 staining was observed compared to control, saline
perfused, kidneys. These data clearly demonstrate that binding of
histones (and probably other cationic proteins) prevents subsequent
binding of JM-403 to HS. This makes it very likely that the absence of
JM-403 staining in SLE nephritis is due to steric hindrance of histone/
DNA complexes bound to HS in the GBM, which supports the
significance of these complexes in SLE nephntis.
The effects of 1-DESAMINO-8-D-Arginine vasopressin (DDAVP) on
renal hemodynamics and renin secretion. H.S. Brink, F.H.M. Derkx, F.
Boomsma, M.A.D.H. Schalekamp, Department of Internal Medicine!,
Erasmus University Rotterdam, Department of Nephrology, University
of Groningen, The Netherlands. I.v. infusion of the selective vasopres-
sin (V2) agonist DDAVP in humans causes a fall in blood pressure and
an increase in heart rate and plasma levels of renin. This suggests that
DDAVP causes vasodilatation. This study was designed to demonstrate
the vasodilating properties of DDAVP in the renal circulation. The
study was performed in 7 male hypertensive subjects (aged 31-63
years), who underwent renal vein catheterization and renal angiography
in the diagnostic work-up of their hypertension. They received an iv.
infusion of DDAVP (0.4 jsglkg in 10 mm). The measurements were
performed before and 15 to 20 minutes after the administration of
DDAVP. The 1311-hippuran clearance was used to measure effective
renal plasma flow (ERPF). Renal plasma flow (RPF) was calculated
from ERPF divided by the extraction ratio of hippuran (Ehip). Angio-
graphy was performed after the end of the experiments. In all patients
the renal arteries were normal and Ehip on the left and right kidney
were not different. The results are expressed as mean SaM.
Before DDAVP After DDAVP
151 6/92 6Blood pressure mm Hg 170 10/106 7
Heart rate bpm 81 6 101 7
ERPF mI/mm 392 41 401 50
Ehip 0.77 0.01 0.73 0.01
RPF mI/mm 505 54 552 65
Plasma renin p11/mI 22 4 65 4
Renal renin secretion mU/mm 2.7 0.2 20.8 0.4
We conclude that stimulation of renal V2-receptors by DDAVP results
in renal vasodilatation and an increase in renal renin secretion. This
provides evidence for the existence of renal V2-receptors apart from the
V2-receptors on the renal tubular cells and the V1-receptors on mesan-
gial and juxtaglomerular cells. The physiological importance of these
receptors remains speculative.
Distribution of cytoskeletal proteins (CP), integrins (IG) and extracel-
lular matrix proteins (ECM) in plastic embedded human and rat kidneys.
W. Coers, H. van Goor, F. Brouwer, S. Huitema, M.L.C. van der
Horst, J. Grond, J.J. Weening, Departments of internal Medicine and
Pathology, University of Groningen, Department of Pathology, AMC,
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Amsterdam. In renal pathology, several studies have focused on
immunohistological identification of CP, IG and ECM proteins, because
these molecules could play an important role in many kidney diseases.
Although a large array of proteins can now be detected in the kidney,
morphological detail is still poor, since most stainings are performed on
cryostat sections. We tried to improve morphological detail in human
and rat kidney by embedding the tissues in a new, low-toxic glycol
methacrylate mixture, especially developed for immunohistochemistry.
Immunohistology was performed on 2 m sections. A number of
polyclonal and monoclonal antibodies to CP (actin, a-actinin, vinculin,
/3-tubulin, keratin, vimentin, desmin), IG (VLA a!, a2, a3, a5, a6, /31,
a5/31, av/33), leukocyte adhesion receptors (/32, LFA-l, MAC-i),
ligands for the VLA IG (collagen IV, fibronectin, laminin, vitronectin)
and LFA-1 (ICAM-i), were successfully applied on plastic embedded
sections of the human kidney with superb morphological detail (Table).
Cross-reacting antibodies were also successfully tested on rat kidney,
with generally the same staining patterns as in the human kidney. The
plastic method presented herein combines superior morphology with
precise immunolocalization and it may therefore prove useful to study
further cell-cell and cell-matrix interactions.
M End Ev Ep GBM/BBM
CP
f3-Tubulin + + ++-I- ++ —
Desmina
Keratinb
Vimentin + -I- +++ + —
Actin + + ++ +++ —
a-actinin + + ++ + —
Vinculin + + + + + + + + —
ECM
Laminin + — — — +++
Fibronec. ++ — — — +++
Coll,IV +++ — — — +++
Vitronec. + ++ ++ ++ —
M End Ev Ep GBM/BBM
IG
al ++ ++ ++ ++ —
a2 — — — — —
a3 + +++ +++ ++ —
a5 + ++ + — —
n6 — ++ — ++ —
av/33
CD18d
— +
+
+++
—
++
—
—
—
CDlla"
CDllbd .
ICAM-l — +÷÷ ++ + —
Immunoreactivity was graded from — (absent) to + + + (abundantly
present). M, mesangium; End, glomerular endothelium; Ev, visceral
epithelium; Ep, parietal epithelium; GBM, glomerular basement mem-
brane; BBM, Bowmans capsule basement membrane, Only positive in
avascular smooth muscle cells, bsome tubular cells, distal tubules and
collecting ducts, dinfiltrating leukocytes.
Sequential immunocytologic examination of urinary sediments in renal
transplant patients. Ph.M.M. Dooper, M.J.J. T. Bogman, A.J. Hoitsma,
T. Machielsen, M. Beukeboom, R.A.P. Koene, Departments of Pathol-
ogy and Medicine, Division of Nephrology, University Hospital Nd-
megen, The Netherlands. Immunocytologic examination of urinary
sediments (UIC) can be used to discriminate acute interstitial rejection
(AIR) from other causes of renal allograft dysfunction. In the urine,
AIR is characterized by an increase of T lymphocytes together with
increased HLA-DR expression on exfoliated renal tubular epithelial
cells. The presence of both parameters, demonstrable by immunocyto-
logical staining with monoclonal antibodies against CD2 (Ti!, Coulter)
and HLA-DR (Becton Dickinson) on cytospin preparations of sedi-
ments, in an indirect alkaline phosphatase technique, was considered
consistent with rejection (R). The presence of only one parameter was
diagnosed as probable rejection (PR). We studied whether sequential
UIC can be used to monitor AIR. Therefore, we examined weekly
urinary sediments in a group of 60 patients, from 2 to 24 weeks after
renal transplantation (Tx) or until rejection occurred. Microscopic
examination was blinded and was retrospectively correlated with clin-
ical data. In 11 patients signs of rejection occurred within the first two
weeks after Tx, during which period the UIC does not give reliable
results. Four patients were excluded because of inadequate follow-up.
In 461 samples of the remaining 45 patients we correctly diagnosed 26
of 30 rejection episodes (19 x R, 7 )< PR). In 21 cases the UIC diagnosis
preceded clinical signs of AIR. In the 15 patients who did not develop
clinical rejection, UIC was false positive in 92 of 258 (40 x R, 52 x PR)
samples. We conclude that the low incidence of false negative diag-
noses makes UIC a sensitive method to rule out AIR. However, the
rather high incidence of false positive diagnoses makes it a less reliable
diagnostic tool in the absence of other signs of rejection.
Identical effects on albuminuria and glomerular filtration rate after one
year treatment with captopril or atenolol in patients with diabetic
nephropathy. L.D. Elving, J.F.M. Wetzels, E. de Nobel, H.J. van Lier,
J.H.M. Berden, Departments of General Internal Medicine and
Nephrology, University Hospital Nzjmegen, N/megen, The Nether-
lands. In a prospective, randomized study 29 patients (23M,6F) with
Type I diabetes mellitus were treated with either captopril 50 to 100 mg(N = 15), or atenolol 50 to 100 mg (N = 14). All patients had overt
diabetic nephropathy with persistent albustix-positive proteinuria and
an endogenous creatinine clearance of at least 30 mI/mm. Seven
patients had hypertension at entry; 4 were randomized for captopril and
3 for atenolol. Mean SD age was 38 11 years and duration of
diabetes was 26 7 years. The changes in mean arterial pressure
(MAP; Dinamap), albuminuria (UabV; laser immunonephelometry) and
glomerular filtration rate (GFR; single shot 51Cr-EDTA) after one year
treatment are shown in the Table. Results are given as median and
range.
MAP mm Hg
Captopril Atenolol
—7 (—35/+7)' 3 (l2/+2)c
UAIbV mg/24 hr —577 (—4424/+1998)" —128 (—i060/+l6)
GFR mI/mm
a p < oo5, bp <
—6 (_34/+6)a
0.02, P < 0.01, for differe
3 (l7/+10)a
nces vs. baseline
After one year of treatment the effects on MAP, UJbV, and GFR did
not differ significantly between the two drugs. An increase in albumin-
uria was seen in three patients with captopril and in one patient on
atenolol; this was not related to changes in MAP or GFR. We conclude
that after one year of treatment both captopril and atenolol significantly
reduced albuminuria and had a similar effect on the progression of overt
diabetic nephropathy.
In vitro and in vivo effects of an anti-interleukin-2 receptor monoclonal
antibody (BT563). T. van Gelder, C.R. Daane, L.M.B. Vaessen, C.J.
Hesse, and W. Weimar, Department of Internal Medicine I, University
Hospital Rotterdam, Rotterdam, The Netherlands. In an attempt to
reduce the incidence of acute rejection after allograft transplantation
several polyclonal and monoclonal anti-pan T cell immunoglobulins
have been added to conventional immunosuppressive regimens. These
preparations induce aspecific immunosuppression and consequently
their use is associated with an increased incidence of infections and
lymphoproliferative disorders. Anti-CD25 monoclonal antibodies
(MoAb) are directed against the interleukin 2 receptor (IL-2R), which is
present on T-lymphocytes, certain B-lymphocytes and macrophages,
when these cells are in an activated state. Therefore their clinical use
might provide a more selective immunosuppression without the com-
plications inherent to aspecific acting agents. We studied in vitro and in
vivo characteristics of a murine IgG 1 MoAb (BT563) directed against
the a chain of the human IL-2R (p55). Mixed lymphocyte reactions
(MLR) were performed in the presence of BT563 in concentrations of
250 to 8000 ng/ml. Compared to other anti-CD25 MoAbs (TU69 and
anti-Tac) BT563 proved to have a stronger inhibitory effect. Maximal
inhibition (90%) was found with levels of 500 ng/ml and higher. This
effect was present even when the MoAb was added on the fourth day of
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the MLR. BT563 was given to 10 patients as rejection prophylaxis after
kidney transplantation. They received 5 to 10 mg/day for 7 days in
combination with low dose steroids. Oral cyclosporine therapy was
initiated at day 5. No major clinical side effects (like fever or hemody-
namic instability) were observed. BT563 plasma trough levels reached
1000 to 2000 ng/ml in the group receiving 5 mg/day and 2000 to 4000
ng/ml in the 10 mg group. T'/2 was 2 to 3 days. No changes in the CD3,
CD4 and CD8 positive lymphocyte subpopulations were registered.
CD25 positive cells remained undetectable from one hour after the first
dose until 6 days after the last BT563 gift. An antimurine IgGI antibody
response was found in all patients tested. None of the patients showed
signs of acute rejection in the first month after transplantation. We
conclude that BT563 is an effective immunosuppressive in vitro in
concentrations that can easily be reached in the clinical situation. Its
value in rejection prophylaxis after allograft transplantation is currently
under investigation.
Human erythrocyte free magnesium concentration difference between
31P NMR and zero point titration. W. Geven, G. Vogels-Metink, J.
Willems, C. van Os, C. Hilbers, J. Joordens, G. Rjksen, and L.
Monnens, Department of Pediatrics, Clinical Chemistry, Physiology
and Biophysical Chemistry, University of Njmegen, the Netherlands.
Intracellular ionized magnesium concentrations [Mg2] estimated in
erythrocytes by 31Phosphorus nuclear magnetic resonance (31P NMR) is
frequently used in epidemiologic studies about hypertension and in
studies about magnesium depletion. The intracellular ionized [Mg2] is
the physiologically relevant fraction of total magnesium, The 31P NMR
method, however, is an indirect technique requiring the use of esti-
mated dissociation constants. To evaluate the 31P NMR method simul-
taneous measurements of [Mg2] were performed with zeropoint
titration in oxygenated erythrocytes from healthy controls and from
patients with isolated renal magnesium loss. In the zero point titration
method, free intracellular magnesium is determined from extracellular
magnesium concentration and total magnesium content of red blood
cells in the presence of the ionophore A 23187. The mean [Mg21] in
controls measured by 31P NMR was 0.20 0.03 mmol/liter cell water,
in contrast to a value of 0.55 0.22 mmol/liter cell water obtained by
zero point titration. Although absolute values for [Mg2J1 differ with the
assay used, significantly lower values for [Mg24]1 were found in patients
with isolated renal magnesium loss by both methods (0.13 0.02 vs.
0.36 0.03 mmol/liter cell water N = 7). For an estimation of the
[Mg24]1 in erythrocytes the zero point titration method is preferable to
the 31P NMR method because it's a more direct approach and not
influenced by dissociation constants.
Prevention of proteinuria by converting enzyme inhibition (CE!) does
not affect mesangial expansion in rats after renal ablation. H. van Goor,
M.L.C. van der Horst, and J. Grond, Department of Pathology,
University of Groningen, The Netherlands. The present study exam-
ined the effect of optimal CE! treatment on the development of focal
segmental glomeruloscierosis (FGS), and each of its structural compo-
nents, that is, mesangial cellularity (MC), mesangial matrix expansion(MME), adhesion formation (Adh), and hyalinosis (H) after renal
ablation. Adult male Wistar rats (N = 25) underwent 3/4 renal ablation
(Nx). From day 4 onwards, 15 randomly selected rats received 50 mg
lisinopril/liter drinking water (NxCEI), controls (NxC) received tap
water. Optimal CE! effect was defined as proteinuria (UprotV) not
exceeding baseline values during 12 weeks after Nx. Six NxCEI rats
fulfilled this arbitrary criterion (2 rats died after Nx) and were further
studied. At 12 weeks NxCE! and NxC rats (N = 7, 3 rats died after Nx)
underwent renal biopsy. At this time point, UprotV in NxC rats was
(median [ranges]) 127 [52—148], in NxCE! 11 [6—21] mg/24 hour (P <
0.01, Wilcoxon's rank sum test). Serum cholesterol (Schol) in NxC was
3.8 [3.0—4.5], in NxCEI 2.3 [2.0—2.7] mmolfliter (P < .01). For histol-
ogy, 2 sm plastic PAS-stained sections were coded and injury scores
were established for FGS, MC, MME, Adh, and H (Lab Invest
64:754—765, 1991). At 12 weeks, FGS score in NxC was 52 [26—156], in
NxCE! 0 [0—4] (p <0.01). Adh score in NxC was 52 [26—152], in NxCEI
0 [0—6] (p <0.01), H score in NxC was 4 [8—40], in NxCEI 0 [0—2] (P <
0.01). Scores of both MC and MME were numerically but not signifi-
cantly lower in NxCE! rats (MC, NxC: 180 [72—2721, NxCE!: 95
[40—210], NS; MME: NxC: 264 [200—302], NxCEI: 220 [136—268], NS).
Macrophage number per glomerular profile (Gm4) in NxC was 1.9
[1.4—3.8], in NxCEI 2.9 [1.0—5.41 (NS). Glomerular volume (GV) in
NxC was 2.10 [1.97—2.21], in NxCE! 2.02 [1.88—2.22] m3 x 106 (NS).
Withdrawal of CE! from 12 weeks to sacrifice at 18 weeks was
associated with significant elevations of UprotV, Schol, Gmçb, GV, and
scores of FGS, Adh and H (all P < .05, Wilcoxon's signed rank test).
MC and MME scores did not change. Significant correlations were
found between log(l+FGS) and U1,,V (r = 0.94) and Schol (r = 0.91).
Adh correlated with UprotV (R = .91) and log(l + H) (r = 0.82) (allP <
0.05, correlation for multiplicity). !n conclusion, although p error may
obscure potential effects on MC and MME, the present data suggest
that optimal CE! from the onset of disease protects remnant glomeruli
from FGS predominantly by prevention of Adh and H, leaving m4., MC,
and MME unaffected.
Renal effects of fetodipine during dopamine blockade. H. W. van
Hamersvelt, J.F.M. Wetzels, H.J. Kloke, R.A.P. Koene and F.Th.M.
Huysmans, Department of Medicine, Division of Nephrology, Univer-
sity of Njmegen, The Netherlands. Calcium entry blockers (CEB) and
dopamine (DA) have many effects in common, such as a natnuretic and
diuretic action, renal vasodilation and inhibition of aldosterone secre-
tion. Therefore, the renal effects of CEB such as felodipine (F) might be
due to interactions with the DA-system. We tested this in a randomized,
single blind, crossover study in 12 healthy male volunteers. Each
subject received two placebo infusions (P + P), an F infusion during
placebo (P + F), and F during DA blockade with metoclopramide, 10
mg/hr i.v. until the end of F (M + F). F was started one hour after M,
initial dose 0.37mg in 1½ hours (low F) followed by 0.63 mg in 1½ hours
(high F). MAP (Dinamap), RPF (PAH clearance), GFR (inulin clear-
ance), fractional excretions of sodium (FENa) and potassium (FEK) and
plasma aldosterone (PAC) were measured. On M alone RPF decreased
by 21 5 mI/mm (P = 0.02). PAC increased from 0.23 0.06 on P to
0.60 0.14 nmol/liter on M (P = 0.01). The other parameters were not
changed by M. F induced absolute changes from pre-F levels are given
in the table (all changes P < 0.05 compared to P + P).
Low F High F
P+F M+F P+F M+F
MAPmmHg
RPF mI/mm
FENa%
FEK %
—3±1
+78 13
+0.8 0.1
+1.0 0.9
—6±1
+63 10
+0.6 o.la
+1.8 0.9
—3±1
+160 26
+1.9 0.3
+1.5 1.1
—5±2
+124 12
+1.6 0.5
+6.3 l.6a
Data are means SEM.
ap < 0.05 compared to P + F
GFR did not change. PAC remained higher during M + F (0.40 0.09
nmol/liter) compared to P+F (0.12 0.03, P < 0.05). !n conclusion, M
only slightly attenuated natnuresis on low F, which could be related to
the lower pre-F RPF on M. Moreover, since DA-blockade did not
inhibit high F natriuresis, it is unlikely that the DA-system plays a major
role in the natriuretic action of CEB. Interestingly, the M mediated
PAC release permitted F to induce a larger kaliuresis, possibly by an F
mediated increase in distal tubular sodium load.
The unfavorable effect of pre-existing proteinuria on long-term renal
function outcome after pregnancy in patients with renal disease. M.H.
Hemmelder, D. de Zeeuw, M.P. Leemhuis, J.G.M. Jordans, and P.E.
de Jong, Department of Internal Medicine, University Hospital, Gron-
ingen; Medical Centre, Leeuwarden and Medical Spectre Twente,
Enschede, The Netherlands. Pregnancy may influence long-term renal
function outcome in patients with renal diseases. To study the fre-
quency and nature of a progressive renal function (RF) deterioration
after pregnancy, we analyzed the course of RF in women with IgA
nephropathy, focal glomerulosclerosis, minimal change disease, mem-
branous glomerulopathy or membranoproliferative glomerulonephritis.
Patients with at least 3 serum creatinine (SCr) values in a period of at
least 1 year before and after one or more pregnancies were included in
the present analysis. Twenty-one patients with 33 pregnancies fulfilled
these criteria. The course of RF before and after pregnancy was
estimated by linear regression of reciprocal S. in time. Worsening of
the rate of progression was based upon at least 2 of the following
parameters: (I) visual evaluation of the regression lines (N = 11), (2)
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change of the slope of the regression line of more than 10 degrees (N =
9), and (3) percentage reciprocal SCr values beneath the extrapolated
initial regression line of more than 75 (N = 10). We found RF to worsen
after 11 pregnancies (group A) and to be stable after 22 pregnancies
(group B). Proteinuria (mean SD) before pregnancy (BP) and in the
third trimester of pregnancy (T3), but not diastolic blood pressure
(DBP) and Sr, was significantly higher in group A.
Group A
(N= 11)
Group B
(N=22) P
Change in slope —17.92 7.55 2.12 12.94 <0.01
(degrees)
%Values below 89 13 33 31 <0.01
regression line
ProteinuriaBP 3.8 2.0 1,9 1.7 <0.05
(giday)
Proteinuria T3 5.8 2.0 2.7 1.8 <0.05
(giday)
We conclude that pregnancy influences long-term RF outcome rather
frequently in patients with renal disease. The level of pre-existing
proteinuria may be a prognostic indicator of the risk of such a
deterioration. Only a prospective human study can give a decisive
answer on this question.
Assessment of post-dialysis dry weight by means of conductivity mea-
surements. P.M. Kouw, C.G. Olthof, A.J.M. Donker, and P.M.J.M. de
Vries, Department of Internal Medicine, Free University Hospital,
Amsterdam, The Netherlands. Correct estimation of clinical dry weight
remains one of the major problems in the clinical practice of hemodi-
alysis. Since post-dialysis over- and underhydration are unfavorable,
and clinical criteria to estimate dry weight are insensitive, more
accurate determination of dry weight is warranted. In the present study
a noninvasive conductivity technique was employed to study regional
intra- (IFV) and extracellular fluid volume (EFV) as a gauge to
determine dry weight. Before and after dialysis conductivity measure-
ments were performed at the lower leg in 29 hemodialysis patients, and
in 31 control subjects with normal tissue hydration. Conductivity values
were translated to regional EFV and IFV values. Values in patients
were expressed as percentages of EFV and IFV in the control subjects.
Decrease in blood volume (dBV) was calculated from erythrocyte
counts before and after dialysis. Before and after dialysis, IFV in
dialysis patients was not comparable to IFV in the control subjects (59
14 vs. 100 20%, P < 0.001), and thus not suitable to mark dry
weight. EFV decreased from 122 29 to 103 30% during dialysis.
The post-dialysis value was comparable to EFV in the control subjects
and, therefore, was studied as a gauge for dry weight. Seven patients
with post-dialysis EFV values higher or lower than the mean 2 SD in
control subjects were considered over- or underhydrated, respectively.
The three underhydrated patients exhibited a significantly higher dBV
per liter ultrafiltration, compared to 22 patients with a normal EFV after
dialysis (P < 0.005). Their pulse rate increased and their blood pressure
fell in contrast to the normohydrated patients. No dBV was observed in
the four overhydrated patients. Since EFV and IFV corresponded with
the measured hemodynamic variables, it can be assumed that assess-
ment of dry weight can be improved by applying the conductivity
technique.
Renal metabolism in endotoxemic rats treated with dopexamine or
dobutamine. A.A. van Lambalgen, A.A. van Kraats, M.F. Mulder, T.
Teerlink, G.C. van den Bos, L.G. ThUs, and A.J.M. Donker, Labora-
tory for Physiology, Central Chemistry Laboratory and Department of
Internal Medicine, Free University, Amsterdam, The Netherlands.
Endotoxin shock causes severe impairment of renal energy status,
ultimately resulting in irreversible cell damage. Dopexamine (DX,
dopaminergic, j32-adrenergic) can increase cardiac output (CO) and
renal blood flow (RBF) in low output states. We have tested if DX,
therapeutically infused during endotoxemia, could prevent renal meta-
bolic collapse. Results were compared with those of dobutamine (DB:
131-adrenergic). Endotoxin (E. coli, 8 mg/kg) was infused from t 0 to
= 60minutes into 28 anesthetized rats. From t = 60 till t = 135 10 rats
received DX (3.10—8 mol/kg . mm; DX-group), 8 rats DB (l0— molt
kg. mm; DB-group), and 10 rats saline (same infusion rate, that is, 2
mI/kg. hr; ES-group). A fourth group served as time matched control
(N = 8; C-group). We measured CO and RBF (radioact. microspheres)
at t = 0, 60, and 135 and lactate, glucose, ATP, and creatine phosphate
(CrP) concentrations in renal biopsies at t = 135. At t = 60CO and RBF
had decreased in all endotoxin-treated rats to 75 and 65%, respectively
(P < 0.05). CO continued to fall in the ES-group only (to 49% at t = 135)
but RBF had further decreased in the ES-, DX-, DB, and C-group (to
38, 55, 55, and 71%, respectively at t = 135;P < 0.05). In renal biopsies
at t = 135 ATP, CrP, and glucose in the C-group were higher (by 68,
100, and 42%, respectively) and lactate was lower (by 84%) than in the
ES-group (P < 0.05). In the DX- and DB-group CrP was higher (by 300
and 211%, respectively) and lactate lower (by 43 and 57%, respectively)
than in the ES-group (P <
.05); in the DX-group, but not in the
DB-group, glucose and ATP were also significantly higher than in the
ES-group (by 87 and 71%, respectively), Our results thus show that
during endotoxemia DB or DX may prevent a further decrease in CO.
but they only partially prevented the further fall in RBF; renal energy
status was preserved, however, and somewhat better in the DX-group
(higher ATP and glucose) probably due to the 132 action of DX.
Pathogenesis of anemia in chronic renal failure. S.A. Luykr-de Bakker,
W.P.L. van Boven, C. van der Heul, and H.G. van Eyk, St. Elizabeth
Hospital Tilburg, Department of Chemical Pathology, Erasmus Uni-
versity, Rotterdam, The Netherlands. The development of recombinant
human erythropoietin (rHuEPO) makes it possible to correct anemia in
patients with end-stage renal disease (ESRD). The doses of rHuEPO
required for the desired increase of hemoglobin vary considerably
between the patients. It seems that other factors than the absolute EPO
deficiency play a role in the anemia in patients with end-stage renal
disease. We studied whether: (a) a reduction in progenitor cells or (b) a
reduction of transferrin receptor synthesis or iron uptake by uremic
erythroblasts, or (c) a difference in the bio-availability of EPO contrib-
ute to this anemia. Stemcell assays as well as incubation experiments
with I125transferrin-Fe59 were performed with bone marrow cells from
patients with end-stage renal disease. Normal bone marrow cells were
stimulated with rHuEPO in vitro with or without sera from patients with
ESRD and healthy volunteers. The erythroid progenitor cells, BFU-E
amounted 561 (± l24)/l0 nucleated cells in patients with ESRD, which
tended to be increased in comparison with healthy volunteers. Mean
transferrin binding to and mean iron uptake by uremic erythroblasts
were 19 resp 75 pmol/2. 106 erythroblasts/hr and are comparable with
normal erythroblasts. The bio-avai!ability studies of rHuEPO showed
that 6 of 8 sera from patients with ESRD contained various concentra-
tions of inhibitors of erythropoietin induced stimulation of bone marrow
cells. Besides an absolute deficiency of erythropoietin, inhibitors of the
bio-availability of EPO may contribute to the anemia of ESRD. The
amount of erythroid progenitor cells, the transferrin binding to and the
iron uptake by uremic erythroblasts seem not to be involved in this
phenomenon.
Complement activation during treatment with OKT3 Implications for
side effects and T cell disappearance. M.H.M. Raasveld, G.E. Hack,
F.N.J. van Diepen, P. Th.A. Schellekens, and R.J.M. ten Berge, Renal
Transplant Unit, Clinical Immunology Laboratory, Academic Medical
Centre, and Central Laboratory of the Netherlands Red Cross Blood
Transfusion Service, University of Amsterdam, Amsterdam, The Neth-
erlands. To further elucidate the pathogenesis of side effects and the
mechanism of T cell disappearance from the circulation during treat-
ment with anti-CD3 monoclonal antibody OKT3, we measured comple-
ment activation products C3a-desarg and C4b/c in plasma of eight renal
allograft recipients during the first three days of anti-rejection treatment
with OKT3. In addition, plasma elastase and lactoferrin were measured
to detect possible activation of neutrophils. Eight renal transplant
recipients, who were treated for acute allograft rejection with methyl-
prednisolone, served as a control group. Plasma C3a-desarg levels
increased from 6.1 1.0 nmollliter (mean SEM) before the first gift of
OKT3 to a peak of 22.9 2.8 nmol/liter at 15 minutes after the first gift
(P < 0.05). Plasma C4b/c levels increased from 57 6 nmol/liter before,
to a peak of 119 12 nmol/liter 30 minutes after the first OKT3
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administration (P < 0.05). Plasma elastase levels increased significantly
from 4.6 0.7 m before, to 8.7 1.6 flM (P < 0.05) at 15 minutes after
the first OKT3 administration and reached their peak at 6 hours (14.3
2.9 nM). Plasma lactoferrin levels that mounted 3.5 0.7 flM before the
first OKT3 administration, were significantly elevated at one hour (8.7
3.2 nas; P < 0.05) and reached their peak at 6 hours (15.7 4.3 nri).
No elevated plasma levels of C3a-desarg, C4b/c, elastase and lactofer-
rin were found either after the second and third gift of OKT3 or in the
control group. In vitro incubation of lymphocytes with OKT3 and fresh
serum led to C3b fixation on virtually all T cells, but to less than 10%
complement mediated lysis. We conclude that the first gift of OKT3
causes immediate activation of the complement system via the classical
pathway and immediate activation of neutrophils. These events may
play a role in the pathogenesis of respiratory side effects that sometimes
occur within minutes after the first OKT3 administration. The immedi-
ate disappearance of T cells from the circulation, occurring after the
first gift of OKT3, is probably in part mediated by binding of OKT3- and
C3b-opsonized T cells to Fcy- and complement-receptor bearing phago-
cytes of liver and spleen.
Serum complement system in children on continuous ambulatory
peritoneal dialysis (CAPD). R.E. Reddingius, C.H. Schröder, M.R.
Daha, L.A,H. Monnens, Department of Pediatrics, Sint Radboud
University Hospital, NUmegen, Department of Nephrology, University
Hospital Leiden, The Netherlands. Complement deficiencies occur in
the nephrotic syndrome due to urinary protein loss. We studied the
complement system in children treated with CAPD with protein loss in
the peritoneal cavity. In 16 patients (mean age 7.0 years, standard
deviation 4.2 years) classical and alternative complement activity and
serum levels of seven components (Clq, C4, C3, C3d, B, D and P) were
measured. Values were compared to a sex- and age-matched control
group of 44 healthy children. Mean total classical complement activity
(CH5O) was 471 U/mi in the CAPD group and 375 U/mI in the control
group (P < 0.025). For total alternative complement activity (AP5O)
there was no difference between the two groups. The mean Clq level
was 14.6mg % in CAPD patients, which was slightly elevated compared
to controls (12.6 mg %; P < 0.025). C4 and especially C3d levels were
markedly elevated. Mean C4 level was 41.9mg % in CAPD patients and
26.9 in controls (P < 0.001). Mean C3d level was 20.4 g/ml in CAPD
patients and 6.7 in controls (P < 0.001). C3 levels were not different in
the CAPD and control groups. Of the measured components of the
alternative pathway (B, D and P) there was a statistically significant
difference between the groups for factors D and P. Mean factor D level
was 103.9 U/mI in CAPD patients, whereas it was only 6.2 in controls
(P < 0.001). Mean properdin level was 21.1 sg/ml in CAPD patients and
16.8 in controls (P < 0.01). It is concluded that there is no deficiency of
complement in these patients. High levels of C3d and D can be
explained as a consequence of reduction of elimination by the kidney.
The increased levels of the other factors are presumably due to an
increased synthesis. The stimulus for this is not yet known.
Anoxia-induced increase of intracellular calcium in rabbit proximal
tubule cells in primary culture. U.M. Rose, C.H. van Os, J.W.C.M.
Jansen, and R.J.M. Bindels, Department of Physiology, University of
Njmegen, Department of Pharmacology, Solvay Duphar B, V. Weesp,
The Netherlands. Renal ischemia eventually results in acute renal
failure. In vivo experiments have demonstrated a protective effect
against ischemic damage by Ca2 entry blockers of the phenylalkyl-
amine group. This suggests a relationship between intracellular Ca2
([Ca2]1) and cell damage as a result of lack of oxygen. In the present
study, a renal epithelial cell model is described in which calcium-related
cell damage during anoxia can be investigated in detail. Primary
cultures of rabbit renal proximal tubule cells (PT cells) on glass
coverslips were loaded with fura-2 AM and mounted in an anoxic
chamber. [Ca2}1 was measured at 37°C using quantitative fluorescence
microscopy. As a result of anoxia, [Ca2]1 increased to a maximal level
within 30 minutes. At the introduction of oxygen [Ca211 returned to
basal or even sub-basal levels. Remarkably, individual cells of mono-
layers responded heterogeneously to anoxia: ECa2i1 increase did not
start simultaneously and different maximal levels were attained. The
increase in [Ca2] could be partly inhibited by the phenylalkylamine
D600 (0.1 mM) or by excluding Ca2 from the extracellular medium
([Ca2]0 < 20 MM). Moreover, addition of 0.1 mri La3 in the absence
of Ca2 completely abolished anoxia-induced increase of [Ca2I1.
These data indicate that [Ca2]1 increases resulted from influx of Ca20.
In order to investigate if [Ca2]1 increase leads to changes in cell
viability, trypan blue staining was performed following anoxic incuba-
tion. In spite of high [Ca21 during anoxia, no change in trypan blue
exclusion could be detected. On the other hand, release of lactate
dehydrogenase (LDH) from the cells into the extracellular medium
during 1 hour of anoxia was 29 5% of total cell LDH, suggesting
plasma membrane damage in at least some cells. In conclusion, in
primary cultures of rabbit renal PT cells anoxia causes a reversible
increase of [Ca2] and LDH release without any change in trypan blue
exclusion.
Fluid kinetics in CAPD patients during dialysis with a hypo-osmotic
solution. D.G. StruUk, R.T. Krediet, G.C.M. Koomen, and L. Arisz,
Academic Medical Center, Amsterdam, The Netherlands. During dia-
lysis using a hypo-osmotic solution, fluid is absorbed from the perito-
neal cavity. We studied the role of lymphatic absorption (LA) in
addition to transcapillary passage of fluid through the peritoneal mem-
brane, Eight stable CAPD patients with a mean age of 48 years (25—75)
and a mean duration of CAPD of 15 months (1—64) were studied during
a 4 hour dwell. The composition of the specially prepared dialysate was:
Na 140, K 3.0, Ca2 1.75, Mg2 1.25, C1 107, HC0340, glucose 10
mmol/liter and osmolality 280 mOsm/kg. Dextran 70 (D; 1 g/liter) and
inulin (2.5 g/liter) were added to the dialysate. LA was determined
assuming a linear disappearance of D, from the amount of D lost,
divided by the product of dwell time and mean D concentration (Dc) in
dialysate. Cumulative transcapillary ultrafiltration (TCUF) at time t,
that is, the change of the intraperitoneal volume (IPV) in the absence of
LA, was calculated as the amount of D instilled, divided by Dc at time
t, minus IPV at the start of the test. IPV decreased in all patients during
the test (mean 396 ml/4 hr range 235—824). LA during the test was 184
63 ml/4 hour (mean SEM). Dc increased during the dwell from 862
69 to 945 81 mI/liter, P = 0.02). TCUF was —120 12 ml after 45
minutes, —136 15 after 60 minutes, —159 21 after 120 minutes and
—212 16 after 240 minutes. TCUF rate was highest during the first
hour compared to the following hours (0—60 mm: 2.3 0.3, 60—120 mm:
0.5 0.2, 120—240 mm: 0.5 0.1 mI/mm; ANOVA P < 0.001). As
expected, dialysis with a hypo-osmotic solution led to absorption of
fluid during a 4 hour dwell. This was caused by LA (fluid with D) as well
as absorption of fluid through the capillaries of the peritoneal membrane
(fluid without D). The lower LA (0.77 mI/mm) compared to dialysis with
hypertonic solutions (1—1.5) could be caused by the rapid decrease of
IPV. The decrease in TCUF rate was probably caused by the rapid
dissipation of the osmotic gradient. As TCUF rate was constant after
the first hour of the dwell, the rate of 0.5 mI/mm is likely to represent
fluid uptake from the peritoneal cavity by the oncotic pressure gradient
between plasma and dialysate.
Shared idiotypes in mesangial deposits in IgA nephropathy (IgAN).
A.W.L. van den Wall Bake, J.A. BruUn, P. Crowley, M.A. Accavitti, R.
Schrohenloher, B.A. Julian, S. Jackson, andJ. Mestecky, University of
Alabama, Birmingham, USA, and University of Leiden, The Nether-
lands. The antigenic specificity of the IgA deposited in the mesangium
in IgAN remains unknown. Restricted usage of certain idiotypes could
provide a clue to the antigenic specificity of the mesangial IgA,
provided that these idiotypes are: (1) shared among patients, and (2)
limited to IgAN. We obtained a nephrectomy specimen from a patient
with primary IgAN, and eluted the IgA. The IgA was purified on
Sepharose CL 4B beads coupled to a monoclonal anti-IgA, and used to
generate murine monoclonal antibodies. Hybridoma supernatants were
screened for preferential binding to the eluted IgA versus human serum
IgA. Five hybridomas showed such preferential binding, and proved to
recognize an idiotypic determinant by screening on human myeloma
proteins. The five hybridomas had an identical pattern of reactivity with
a panel of 48 paraproteins, and showed cross-inhibition of binding. This
suggests recognition of the same idiotypic determinant, and raises the
possibility of a dominant idiotype in the mesangial IgA. The idiotype
was also detected in human serum IgA, PEG precipitates, and in 6.3
1.4% of pokeweed mitogen-induced plasma cells. The idiotype was
restricted to K immunoglobulins. Indirect immunofluorescence showed
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this idiotype in glomerular deposits in several disorders with the
following frequencies:
Disease (+)/Total
IgAN 26/31
Recurrent IgAN in transplant 6/6
Henoch-Schoenlein purpura 6/6
SLE 8/8
Membranous glomerulonephritis 7/7
Membranoproliferative GN 4/5
Cryoglobulinemia 3/4
In conclusion, although a shared idiotype was found in patients with
IgAN, it was also found in other types of renal disease.
Ileparms modulate the composition of extracellular matrix (ECM)
produced by cultured rat mesangial cells (MCs). A. Woithuis, A. Boes,
J.H.M. Berden, and J. Grond, Department of Pathology, University of
Groningen, and Department of Medicine, Division of Nephrology,
University of Nrnegen, The Netherlands. Rat glomerular epithelial and
endothelial cells secrete heparin-like species which inhibit the prolifer-
ation of MCs in vitro, thus heparins may have a role in the regulation of
MC turnover. In this study, we examined the effects of heparin (hep)
and desulfated acetylated heparin (DSA-hep, devoid of anticoagulant
activity) on the composition of ECM, another determinant of MC
growth and biosynthetic activity. Cultured rat MCs (passage # 8—10)
were growth arrested and synchronized in GIG by incubation in
medium with 0.5% FCS for 72 hours. Proliferation studies revealed a
dose-dependent growth inhibition and delayed entry into the S phase
after release from G0/G1. ECM synthesis was studied by analysis of
collagen IV (CIV) and fibronectin (FN) production. MCs plated in
various densities were incubated with medium containing 10% FCS and
100 sg/ml hep or DSA-hep for 3 days. The quantities of secreted CIV
(SeCIV) and matrix/cell-associated CIV (CaCIV) were determined by
equilibrium competition ELISA. CaCIV was measured after solubiliza-
tion of matrix/cell layer. Both SeCIV and CaCIV amounts per cell
showed highly significant negative relationships with increasing cell
densities (range: iO—lO MCs/2 cm2; confluency at cells/2 cm2).
However, incubation with hep or DSA-hep did not affect CIV produc-
tion. Production of SeFN and CaFN was studied by sandwich ELISA,
SeFN per cell was inversely related to cell density similarly to CIV
suggesting that the downregulating effects of increasing cell density on
secreted ECM proteins are generalized. Both hep and DSA-hep re-
duced the amount of SeFN by 20% of control values (l0 cells/2 cm2);
P < 0.05, respectively, P < 0.01, multiple linear regression, MLR). Of
note, CaFN showed a biphasic relationship with cell density after
double log transformation: a first stratum with a positive linear relation
until confluency and a second stratum showing a negative linear relation
at confluency/supraconfluency (l0 cells/2 cm2). Both hep and DSA-
hep increased the amount of CaFN per cell resp 50% (P < 0.001, MLR)
and 20% (P < 0.005, MLR) over control values in subconfluent MCs, no
effects were seen in CaFN content of confluent and subconfluent MCs.
In conclusion, hep and DSA-hep increase the ECM component FN, an
adhesive glycoprotein with ability to modulate adhesion, migration,
growth, and phagocytosis of diverse cell types including MCs.
Prostaglandlns and peritoneal permeability during the time course of
peritonitis in CAPD. D. Zemel, G.C,M. Koomen, D.G. Struzjk, B.A.C.
van Acker, and R.T. Krediet, Renal Unit, Academic Medical Center,
Amsterdam, The Netherlands. Peritoneal permeability is probably
influenced by locally produced vasoactive substances. We studied the
effective peritoneal surface area (EPSA) and intrinsic peritoneal per-
meability (IPP) during peritonitis (P) and their possible relationship with
prostaglandins (Pg) in peritoneal effluent (E). Eight CAPD patients were
examined on 8 consecutive days from the onset of P and once after
recovery (control). Clearances (Cl) of /32microglobulin (/32m), albumin
(alb), IgG, IgA and a2macroglobulin (a2m) were determined daily in E
(nightbags), as well as PGE2, 6kFla and TxB2. Ratio Dilating Pg/
Constricting Pg (D/C) was calculated as (PGE2 + 6kFla)/(TxB2), C1f32m
was used as indicator of EPSA. IPP was characterized by the peritoneal
restriction coefficient (rc). Low rc means high IPP. Median Cl (t.d/min)
and Pg (pg/ml) decreased from day 1 to control. /32m: 1422 to 922, alb:
243 to 107, IgG: 163 to 57, IgA: 136 to 49, a2m: 78 to 16, POE2: 595 to
56, 6kFla: 633 to 71, TxB2: 78 to 16, D/C: 19 to 6. Re increased from
1.74 to 2.17. Rank correlations (N = 72) were found between relative
values (control = 100%)of Ctp2m and POE2, 6kFl a and TxB2 (r  0.41,
P < 0.001). Rc correlated inversely with POE2 and 6kfla (r —0.25, P
<0.05) and D/C (r —0.35, P < 0.001). Maximal changes between P
and control () of Cl/32m ranged from 37 to 581% among patients
(median 88%), Me from 2 to 37% (median 20%). Me was associated
with PGE2 (N = 8, r = 0.69, P = 0.06), but Cli3m was not. In
conclusion, elevated Pg during P were related to both increased EPSA
and IPP. However, LEPSA varied highly interindividually, independent
of Pg. MPP was smaller and associated with iPGE2. This suggests
that the relationship of peritoneal permeability with Pg during P is more
directly related to IPP than to EPSA. Other mediators may be involved
as well.
